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Rift Valley fever threatens human and animal health. 
After a human case was confi rmed in Comoros in 2007, 4 
serosurveys among ruminants in Mayotte suggested that 
Rift Valley fever virus had been circulating at low levels 
since 2004, although no clinical cases occurred in animals. 
Entomologic and ecologic studies will help determine 
outbreak potential. 
Rift Valley fever virus (RVFV) usually causes large, explosive epidemics among animals and humans 
and circulates in many African countries and the Arabian 
Peninsula (1–3). The human and veterinary medical role 
of this mosquito-borne virus was highlighted at the end 
of 2006 and early 2007, when a large epidemic/epizootic 
occurred in eastern Africa (4,5) and Madagascar, during 
2 successive rainy seasons (6,7). More recently, South 
Africa and Mauritania were severely affected (8,9). This 
wide dissemination potential emphasizes that Rift Valley 
fever constitutes a threat for human and animal health 
on the African continent and beyond.  In Mayotte in July 
2007, recent RVFV infection was detected in a 12-year-
old boy with a severe neuroinvasive illness. This patient 
had recently arrived from Grande Comore, Union of the 
Comoros, where RVFV circulation had been confi rmed 
(10–12). 
Starting in April 2008, given the proximity of Comoros 
and Mayotte and considering the risk for introducing RVFV 
by illegal animal movements, active laboratory-based 
surveillance for Rift Valley fever was implemented among 
susceptible ruminants in Mayotte. A series of 4 serosurveys 
was designed to clarify the epidemiologic situation. The fi rst 
survey captured information about goats and cattle illegally 
introduced to the northern part of the island of Mayotte, the 
site of most illegal imports because of its proximity with 
the Comoros island of Anjouan (Figure 1). The second 
survey was a retrospective islandwide serologic survey of 
ruminant samples collected during 2007–2008, intended 
to capture a broader view of the situation. The third 
survey was a 4-year retrospective serosurvey of ruminant 
samples collected during 2004–2007, intended to increase 
knowledge of the history of the virus on the island. The 
fourth survey, a longitudinal serologic study on goat farms, 
assessed whether the virus was still circulating in 2008.
The Study
The fi rst survey, intended to clarify the Rift Valley 
fever epidemiologic situation on the island, was undertaken 
in the M’Tsangamouji area (northern part of Mayotte). It 
examined samples from 29 illegally introduced goats and 79 
cattle born on the island and living near the goats. Among 
the 29 goats, competitive IgG ELISA found IgG against 
RVFV in 4 goats that had been introduced illegally during 
November 2007–April 2008 (13), and IgM-capture ELISA 
found IgM against RVFV in 2 goats (14), suggesting recent 
infection. Among the 79 cattle, IgG against RVFV was 
found in 29 (37%) and IgM against RVFV was found in 
3 (4%). 
These data led us to conduct the second survey, a 
retrospective study on the whole island to defi ne the 
geographic distribution of the infection and to trace back 
the period of introduction. This survey analyzed 301 cattle 
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Figure 1. Potential legal and illegal movements of animals around 
the Comoros and Mayotte.
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serum samples collected during June 2007–May 2008 on 
104 farms in 17 districts. Exposure to RVFV was indicated 
by competitive IgG ELISA detection of RVFV-specifi c 
antibodies. Positive results were found for 32 samples from 
cattle in 9 districts (Table). The overall apparent RVFV 
seroprevalence of 10.6% (95% CI 7%–14%) was supported 
by the high specifi city of the ELISA (14). The 32 positive 
samples came from cattle distributed all over the island 
(Figure 2, panel A). 
Because RVFV circulation had been confi rmed as 
early as 2007–2008 in Mayotte, a third cross-sectional and 
retrospective study was conducted to trace previous virus 
circulation. The 120–130 samples that had been collected 
from cattle since 2004 were randomly selected every year 
over a 4-year period and analyzed by IgG ELISA; results 
were confi rmed by neutralization tests (15). These results 
helped evaluate RVFV circulation on Mayotte island 
before the 2007–2008 outbreak on the eastern Africa 
mainland. In 2004, a total of 29 of 130 cattle had IgG 
against RVFV; thus, seroprevalence was high (22.66%). 
In 2005, seroprevalence rates fell; IgG against RVFV was 
found in only 4 of the 130, suggesting low levels of RVFV 
circulation. In 2006 and 2007, seroprevalence increased; 
IgG against RVFV was found in 16 of 130 and 39 of 126 
cattle, reaching seroprevalence rates of 12.31% and 30.95% 
for 2006 and 2007, respectively. Specifi c IgM against 
RVFV was not detectable during this cross-sectional and 
retrospective study.
The fourth survey, intended to evaluate the recent virus 
dynamics in Mayotte, was a longitudinal serologic survey 
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Table. Rift Valley fever virus seroprevalence among cattle, 
Mayotte, June 2007–May 2008 
District No. positive/no. tested Seroprevalence, % 
Acoua 0/6 0
Bandraboua 5/31 16.13
Bandrele 0/6 0
Boueni 0/1 0
Chiconi 0/9 0
Chirongui 1/3 33.33
Dembeni 7/32 21.88
Dzoumogne 0/1 0
Kahani 1/5 20
Kani Keli 3/26 11.54
Koungou 0/10 0
Mamoudzou 0/28 0
Mirereni 1/2 50
Mtsangamouji 6/21 28.57
Ouangani 3/40 7.50
Sada 0/20 0
Tsingoni 5/60 8.33
Total 32/301 10.63
Figure 2. Rift Valley fever in Mayotte, by municipality. A)  Human cases and animal and herd seroprevalence. Values under municipality 
names are seroprevalence by herd (no. infected herds/no. herds) and, in parentheses, by animal in infected municipalities (no. infected/
total no.). B) Status of goat herds sampled for longitudinal serologic study, Mayotte, 2008–2009.
of goat farms. In June 2008, a total of 13 goat farms were 
selected and all 272 animals were screened for antibodies 
against RVFV. Of the 13 farms, 8 had seropositive animals 
(herd prevalence 62%, 95% CI 35%–88%) (Figure 2, panel 
B). Intraherd prevalence ranged from 6% to 42%. The 5 
farms with seronegative goats (total 70 goats) were included 
in the longitudinal study. During August 2008–August 2009, 
the seronegative goats were sampled every 6–8 weeks. Only 
1 goat, located in Bouyouni and sampled in February 2009, 
had seroconverted and was confi rmed IgM positive for 
RVFV. Virus isolation attempts were unsuccessful.
Conclusions
The 4 serologic surveys conducted in Mayotte 
revealed medium to high rates of RVFV prevalence all 
over the island. The high rates obtained with the fi rst 
survey in the M’Tsangamouji area suggest that illegal 
animal movements from the Comoros are a likely source 
for RVFV introduction onto Mayotte. Results of the 4-year 
survey show that the virus was already present in 2004. 
After a low seroprevalence rate in 2005, the increased 
seroprevalence rates for 2006 and 2007 suggest that the 
virus had recirculated or had been newly introduced.
It is unclear why relatively high circulation of RVFV 
in Mayotte and an increased rate of seroprevalence to 22% 
did not result in detectable clinical cases in animals while 
Rift Valley fever was diagnosed for humans with brain 
disorders (11). This fi nding might be because the density 
of susceptible animals on the island was high enough to 
support virus circulation but too low to support waves of 
epidemic abortion and death. These study fi ndings, coupled 
with epidemics in eastern Africa, illustrate the risk for 
introduction of infectious agents from the African mainland 
to Mayotte or other Comoros islands. Entomologic studies 
need to be conducted to identify all potential vector species 
on the island and to better understand the ecologic and 
climatic factors that favor RVFV dissemination. The 
ecologic factors in favor of Rift Valley fever outbreaks 
might be comparable between Mayotte, the other Comoros 
islands, Madagascar, and the eastern African mainland 
(Kenya, Tanzania, and Mozambique) but need to be looked 
at more closely. In Mayotte, an entomologic surveillance 
program is being developed to help defi ne the distribution 
of potential vectors in association with virus circulation and 
provide better understanding of disease spread mechanisms. 
The role of wildlife should also be investigated. These data 
highlight the need for extensive studies to determine RVFV 
distribution and to evaluate the effect of Rift Valley fever 
on the susceptible livestock populations.
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